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AbsTRACT
Glanders is a common infectious disease of horses in certain parts of the world. The disease also affects 
other animal species and is of zoonotic importance. The causative agent is newly classified under the genus 
Burkholderia and the biochemical characteristics of the bacteria are listed. Clinical signs of the disease vary 
among horses but may be manifested by cutaneous nodules, bronchopneumonia and/or nasal ulceration. The 
diagnosis, differential diagnosis, treatment and control of glanders are discussed. 
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introduction
Glanders is primarily a disease of the skin, lymphatics, and respiratory tract of mature 
horses (RAF, 1984; JULINI, 1990). Aristotle made the first authentic description of the 
disease in horses in 330 b.c. under the name malignant or bad disease (HENNING, 1956). 
Many synonyms have been given to this disease, including cutaneous Droes, Farcy, Farcy 
Pipes, Farcy Buds, Malleus or Equinia. However, glanders has generally been accepted 
as the term of choice (JUBB et al., 1985). There are many clinical disorders associated 
with glanders which have been recognized with increased frequency in horses (RHEE et 
al., 1986; SINGH and YADAV, 1989). Only a few reports have appeared with regard to the 
occurrence of glanders in humans. These have been associated with persons handling 
glanderous animals, especially veterinarians (HOWE and MILLER, 1947; GANGULEE et al., 
1966). Prophylaxis involves the elimination of all affected horses, routine mallein testing 
of all exposed animals, and disinfection of the premises (THEVES, 1993; YEHYA, 1994; 
*Contact address:
Jerry Roberson, DVM, PhD, Department of Large Animal Clinical Sciences, 2407 River Drive, University of Tennessee, 
Knoxville, TN. 37996-4545, USA. Phone: 865-755-8256, Fax: 865-974-5773 E-mail: jrobers8@utk.edu
204 Vet. arhiv 77 (3), 203-218, 2007
NAGAL et al., 1995). The purpose of this review is to provide an update on the existing 
knowledge of glanders.
etiology
Table 1. Major biochemical properties of Burkholderia mallei




Galactose + 100 
Mannose + 100
Lactose + 100
Sucrose -  0
Maltose + or -  64
Mannitol + 100 
Arginine dihydrolase + 100
Oxidase + 100
Indole - 100
Motility -  0 
Gelatin liquefaction - 100
Voges-Proskauer - 100
+ = Positive; - = Negative
After the verification of glanders as a clinical entity, scientists started investigating 
the specific etiology. Workers in Germany reported that equine glanders was caused 
by an organism, which they termed the glanders bacillus. FLUGGE (1967) called the 
organism Bacillus mallei. Other scientists proposed the name Loefflerella mallei and 
then Pfeifferella mallei (HENNING, 1956). MERCHANT and PACKER (1967) preferred the 
inclusion of the causative organism in the genus Malleomyces. At Cambridge, taxonomists 
placed the glanders organism in the genus Pseudomonas (WETMORE and GOCHENOUR, 
1956; SMITH and CHERY, 1957; ROGUL et al., 1970). It was the only non-motile species in 
the genus Pseudomonas and required differentiation from P. pseudomallei (SMITH and 
CHERY, 1957; ROSE and FRIEDMAN, 1980). Taxonomists then classified glanders bacilli 
in the genus actinobacillus (EVANS, 1966). The current name, Burkholderia mallei, was 
proposed in the early 1990’s (YABUUCHI et al., 1992). The new name was based on the 16s 
rRNA sequences, DNA-DNA homology values, cellular lipid and fatty acid composition, 
and phenotypic characteristics (YABUUCHI et al., 1992). The organism is a non-motile, 
non-spore forming, Gram-negative, aerobic slender rod with rounded ends, 2-5 µm long 
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and 0.5 µm wide. Electron microscopy showed that B. mallei have a nucleus, particulate 
cytoplasm and triple-layered profile of the outer unit membrane component of the cell 
wall. The cell envelope consisted of a number of different structural layers (AL-ANI et 
al., 1992). When cultured on suitable media for 1 to 2 days, the organism produced small, 
round amorphous translucent colonies (WETMORE and GOCHENOUR, 1956; REDFEARN 
et al., 1966; POPOV et al., 1991). The characteristics of 14 equine isolates of B. mallei are 
shown in Table 1 (AL-ANI et al., 1998).
Transmission
The mode of infection and transmission of equine glanders has been debated for several 
years but it is generally agreed that most transmission occurs by ingestion. According to 
HUTYRA and MAREK (1926), utensils and contaminated food and water could play a role 
in the transmission of the disease. The degree of survival of the glanders bacilli in tap 
water indicated that water sources might remain infectious to animals and man for several 
weeks after contamination (GANGULEE et al., 1966). Burkholderia mallei may be isolated 
from the manure and the skin of carrier animals. Risk factors for transmission include 
unsanitary and crowded stable conditions where infectious secretions may be directly 
passed from one animal to another, or indirectly by use of common grooming instruments 
(RADOSTITS et al., 1994). Experimental intratracheal deposition of B. mallei produces 
clinical glanders (LOPEZ et al., 2003). The common house fly (Musca domestica) may play 
an important role in the spread of glanders when feeding on the oozing lesions of a horse 
with glanders (HENNING, 1956).
Glanders of horses may occur when crowding and unsanitary conditions prevail (AL-
ANI et al., 1987; JERABEK, 1994; NAGAL et al., 1995). All breeds and sexes of horses are 
susceptible to the disease, but animals over two years of age are more susceptible to 
cutaneous farcy (JUBB et al., 1985; RADOSTITS et al., 1994). Although the disease may 
develop during any season, its incidence is highest among horses exposed to severe 
cold weather. Horses receiving inadequate nutrition and kept under poor environmental 
conditions are the most susceptible (Al-ANI et al., 1987).
occurrence
In Iraq, the disease has been reported in the Baghdad province (AL-ANI et al., 1987; 
AL-ANI et al., 1998). The disease still exists in the Middle East (YEHYA, 1994), in India 
and Pakistan (VAID et al., 1981; RAY, 1984; UPPAL and YADAV, 1987; KRISHNA et al., 1992; 
NAGAL et al., 1995), in Vietnam and Korea (HEO et al., 1987; PARK et al., 1988; SUGIYAMA, 
1993), parts of Africa (HENNING, 1956), Italy (GALATI et al., 1973), and China, Russia 
and Mongolia (ZHANG and LU, 1983). The disease, widespread in United Kingdom in 
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the nineteenth century, was finally eradicated in 1928. The disease was eliminated from 
horses in the United States during the 1940s (WISER et al., 1986). 
Animal susceptibility
Glanders is a highly communicable disease of horses, mules and donkeys 
(MAHADEVAN et al., 1987; THEVES, 1993). Horses tend to be chronically affected, 
whereas donkeys and mules develop the acute form. Apparently recovered animals 
remain carriers. Dogs and cats may be infected. Wild animals may develop the disease, 
especially members of the cat family, including lions that have been fed on infected horse 
meat (HART, 1916; GALATI et al., 1973; ALIBASOGLU et al., 1986). Infections have also 
been reported in sheep and goats (HU et al., 1958). Guinea pigs and hamsters are reported 
to be highly susceptible, and die within twenty-four hours following the inoculation of a 
massive dose, and within 3 weeks after a small one (HENNING, 1956).
Glanders in man
Glanders is zoonotic. It is rare in humans and no epidemics have been reported. 
Human cases of glanders have occurred in veterinarians and animal caretakers, and in 
occupational settings such as laboratories. The disease is usually acquired through direct 
skin or mucous membrane contact with infected animal tissues (BALLARINI, 1985). The 
disease in man occurred in Russia during World War I. Chronic glanders in man has been 
described by a British veterinarian who contracted the disease in India (GANGULEE et 
al., 1966). Although glanders had been eradicated from horses in the United States in the 
1940s, one recent human case of glanders was reported in a laboratory worker in 2000 
(SRINIVASAN et al., 2001). This was the first human case reported in the United States 
since 1945 (CDC, 2000). During World War II, six unrelated cases of laboratory-acquired 
infection with B. mallei occurred at Camp Detrick, Frederick, Maryland (CDC, 2000). 
Some of these cases were attributed to inhalation of infectious aerosols generated by 
spillage of liquid culture media containing the bacterium, although some cases occurred 
due to cutaneous injuries (VESLEY and HARTMAN, 1988; SUGIYAMA, 1993; WHEELIS, 
1998; McGOVERN et al., 1999). 
Four clinical manifestations of B. mallei infection in man have been described 
(ROBINS, 1906; BERNSTEIN and CARLING, 1909; MILLER et al., 1948; GANGULEE et al., 
1966). The pneumonic form may develop when bacteria is aerosolized and enters the 
respiratory tract via inhalation or haematogenous spread. The incubation period is 1 to 
14 days. Pneumonia, pulmonary abscesses, and pleural effusions may occur (UPPAL and 
YADAV, 1987; WILKINSON, 1993). Generally, there is fever, mucopurulent nasal discharge 
and a generalized pustular skin eruption. Death invariably occurs in 7 to 10 days. The 
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disease attacks chiefly those who come into close contact with horses, such as ostlers, 
groomers and coachmen (HOWE and MILLER, 1947; RAF, 1984; RAY, 1984). The localized 
form occurs when bacteria enter the skin through a laceration or abrasion, and a local 
infection with ulceration and/or nodular formation develops. Incubation period is 1-5 
days. Swollen lymph nodes may develop. The septicemic form is usually fatal within 7 to 
10 days. The septicaemia that develops affects multiple systems, including the skin, liver 
and spleen (HOWE and MILLER, 1947). The chronic form occurs when multiple abscesses 
develop in the liver, spleen, skin, or muscles. This form also is known as “farcy”.
Pathogenesis 
Miller and his group studied the virulence of B. mallei. Their work revealed that 
strains of very low virulence of B. mallei produced subacute or chronic infection in 
hamsters, moderately virulent strains produced acute fulminating infections in hamsters 
and ferrets, and subacute or chronic infection in guinea-pigs, while virulent strains caused 
the acute fulminating form of the disease in hamsters and guinea-pigs (MILLER et al., 
1948). The development of small animal models has allowed an assessment of the role 
of a number of putative virulence determinants in the pathogenesis of glanders in horses 
(LOPEZ et al., 2003). Experimental studies by HU (1958) and his colleagues showed that the 
intravenous or intratesticular inoculation of B. mallei produced acute toxaemia and rapid 
death in sheep and goats. The subcutaneous injection was also lethal to sheep and goats 
but the infection was less acute. These authors concluded that the virulence of the strain is 
responsible for the type of disease produced, and might explain the occurrence of all the 
gradations of glanders in horses (HU et al., 1958). Ingestion is the main route of infection 
(RADOSTITS et al., 1994). This could be explained by the presence of glanderous lesions 
in internal organs as well as causing orchitis (ZUBAIDY and AL-ANI, 1978; MOHAMMAD 
et al., 1989). The lungs and upper respiratory passages appear to be the predilection sites 
(ZUBAIDY and AL-ANI, 1978). Emboli in pulmonary and nasal vessels might be evidence 
that the organisms are carried to the blood when acquired by ingestion, inhalation or 
through cutaneous wounds entering the lymphatic system and general circulation and 
localize in the lungs from which they spread to the nasal passages (ZUBAIDY and AL-ANI, 
1978).
Clinical signs and pathological changes
The incubation period is 2 to 3 days following intratesticular injection of B. mallei. 
Contact infections usually require 2 weeks, but exceptionally virulent strains might require 
only 7 to 10 days (AL-ANI et al., 1998). The highly variable incubation period under field 
conditions (a few days to several weeks or months) led to an arbitrary classification of the 
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disease into two forms: clinical and subclinical or latent glanders (HUTYRA and MAREK, 
1926).
In the author’s (Al-Ani) experience, equine glanders can be classified into four forms: 
cutaneous, pulmonary, nasal, and asymptomatic carrier (AL-ANI et al., 1987). Cutaneous 
glanders may result from skin injury or may be due to a secondary manifestation of the 
respiratory form. It consists of nodules, pustules and ulcers that occur over any part of 
the body but are most frequently observed on the legs (MOHAMMAD et al., 1989; AL-ANI 
et al., 1992). These nodules usually appear in chains along the course of the lymphatic 
vessels. Initially, the lesions appear as nodules, which tend to break down and form 
crater-like ulcers discharging thick yellowish viscid and sticky purulent material heavily 
laden with the glanders organism. This is usually referred to as farcy pipes. Like other 
bacterial infections, glanders induces a neutrophilic leukocytosis in the infected horse 
(AL-KAFAWI et al., 1977). Also, B. mallei infection causes severe anaemia probably 
because of depressed erythropoietic activity of the bone marrow (AL-KAFAWI et al., 1977). 
The pulmonary form of equine glanders is the most common clinical manifestation of 
the disease. It is characterized by the formation of round, greyish, firm, encapsulated 
nodules embedded throughout the lung tissue (ZUBAIDY and AL-ANI, 1978). Cough and 
high fever reflect the fulminating bronchopneumonia that characterizes the acute form. At 
necropsy, most of the pulmonary lesions are discrete firm miliary granulomatous nodules 
which have a caseonecrotic centre with degenerate neutrophils (ZUBAIDY and AL-ANI, 
1978). The nasal form of glanders appears in the form of nodules or ulcers in the upper 
air passages. The ulcers are commonly seen on the lower parts of the turbinate and on 
the cartilaginous nasal septum (JUBB et al., 1985). A bloody mucopurulent nasal discharge 
appears when those nodules rupture. The asymptomatic carrier form of glanders develops 
after a period of illness of some months. The affected equine makes an apparent recovery 
but persists as an occult case. Mallein test is positive but no obvious skin lesions can be 
seen (AL-ANI et al., 1987).
Diagnosis
Glanders may be diagnosed based on clinical signs, the mallein test, serological 
tests and bacterial isolation (ALLEN, 1929; UPPAL and YADAV, 1987; THEVES, 1993; 
PRITCHARD, 1995). The following diagnostic tests can be performed:
1. Isolation and identification of the causative agent.
Culture of B. mallei from an unopened cutaneous nodule, lymph node or pulmonary 
lesion is of diagnostic value (AL-ANI et al., 1998). Cultured swabs of the purulent contents 
on glycerin agar reveal small, round, amorphous, translucent colonies (MILLER et al., 
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1948; QUINN et al., 1994; OIE, 1996). Its Gram stain morphology, biochemical activities 
and male guinea-pigs inoculation (MILLER et al., 1948; AL-ANI et al., 1998) can identify 
B. mallei. Many different media have been developed to support the growth of B. mallei 
(ROGUL et al., 1970). Brain heart infusion agars supplemented with 3% glycerin have 
been used to propagate the organism in large quantities. The Straus reaction is performed 
by the intra-peritoneal injection of male guinea pigs with suspected materials to help in 
diagnosis. Swelling and periorchitis occur 3 to 7 days post-inoculation.
2. Cell- mediated immunity tests.
An in vivo test of cell-mediated immunity includes the commonly used 
intradermopalpebral mallein test (ROSE and FRIEDMAN, 1980; VERMA et al., 1994; OIE, 
1996). The test is performed by injecting 0.1 mL of mallein into the skin close to the 
edge of the lower eyelid. A positive reaction usually develops within 48 to 72 hours and 
is characterized by marked oedema of the lid with blepharospasm and severe purulent 
conjunctivitis. The mallein test has a positive predictive value of 92% in acute and chronic 
cases and a negative predictive value of 96% in advanced cases (WILSON and MILES, 
1975). Others have reported limitations in sensitivity, especially in clinically advanced 
cases, (JANA et al., 1982) and false-positives associated with streptococcus equi infections 
(AL-ANI, 1987). The mallein test may cause uninfected horses to produce antibodies 
against B. mallei causing a positive complement fixation test (CFT) (HAGEBOCK et al., 
1993). An in vitro test of cell-mediated immunity is the lymphocyte stimulation test. A 
combination of lymphocyte blastogenesis, CFT and culture for the diagnosis of glanders 
yields high sensitivity and specificity rates.
3. Serological tests.
Serological tests have the greatest application in epidemiological investigations. The 
presence of more than one isolate in an area might complicate the serologic interpretation, 
although variable data indicate that common antigens are shared by different isolates 
(MISRA and ARORA, 1990).
a. Agar-gel immunodiffusion (AGID) test.
The AGID test has been used successfully as a screening test for the diagnosis of 
glanders (SEN et al., 1968; AL-ANI, 1989). The main disadvantage of this test is that large 
amounts of antibodies (a titer ≥ 1:128) are necessary to produce visible precipitin lines. 
The AGID test is rapid, inexpensive and accurate in clinical cases of glanders and results 
are available within 48 hours.
b. Counterimmunoelectrophoresis (CIE) test.
Counterimmunoelectrophoresis is based on the principle of immunodiffusion 
modified by the electrophoretic driving of the antigen and antibody towards each other. 
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The test is currently used to detect antibodies in the sera of infected horses (JANA et al., 
1982). This test is rapid, simple, economic and suitable for the screening of a large number 
of sera.
c. Fluorescent antibody (IFA) test.
The IFA technique has been developed for diagnosis of glanders (MA et al., 1986). 
Of 53 naturally affected mules, 47 were positive to IFA, in close agreement with that of 
ELISA (MA et al., 1986). It was concluded that IFA is quick and simple for the diagnosis 
of glanders. Also, IFA distinguishes between the antigens of B. mallei and the antigens of 
other bacteria, which are easily confused by the CFT. 
d. Indirect haemagglutination (IHA) test.
Passive HA test can be routinely used for herd diagnosis and survey purposes (AL-
ANI et al., 1998). Titers ≥ 1:80 are regarded as positive. In India, an HA titer of 1:640 is 
considered positive (GANGULEE et al., 1966). 
e. Complement Fixation Test (CFT).
The CFT has been used as a reliable test for the diagnosis of glanders (SEN et al., 1968; 
VERMA, 1990; AL-ANI et al., 1992). A titer of 1:32 may be regarded as positive. POPPE 
(1919) tested 2665 by CFT. His results showed that 26 horses gave false-positive results 
and 59 horses gave false-negative results. There is general agreement that the CFT is 
superior to other serological methods in diagnosis of glanders (SEN et al., 1968; AL-ANI 
et al., 1993). However, according to WILSON and MILES (1975), CFT may give a positive 
cross-reaction in horses suffering from strangles, equine influenza or petechial fever, and 
in emaciated horses not suffering from glanders. 
f. Enzyme linked immunosorbent assay (ELSA).
The ELISA has been developed recently (NIEDERWOHRMEIER and BOHM, 1990; 
VERMA et al., 1990; AL-ANI et al., 1993). In a comparative study conducted in Iraq, 125 
horses’ sera were tested by ELISA, CFT, AGID and HA and compared with culture 
results. Results showed that ELISA correctly identified 100% of confirmed clinical 
cases of horses with glanders, whereas the latter tests gave only 90.9% positive reaction 
(AL-ANI et al., 1993). Thus, ELISA test could be routinely adopted as a highly sensitive 
diagnostic test for glanders.
g. DNA-sequencing and Polymerase Chain Reaction (PCR) using primers to amplify 
part of the bacterial genome have been developed to differentiate between glanders, 
melioidosis and other related organisms (YABUUCHI et al., 1992; GEE et al., 2003; GODOY 
et al., 2003). The use of 16S rRNA gene sequencing to rapidly identify B. mallei, B. 
pseudomallei, and differentiate them from closely related organisms by a molecular 
method, has been used (GEE et al., 2003).
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h. Bacteriophage specific for B. mallei has been developed (WOODS et al., 2002). 
Bacteriophage phiE125 has been found to form plaques on B. mallei but not on any other 
bacterial species tested, including B. thailandensis and B. pseudomallei. 
Differential diagnosis
Glanders might be clinically confused with epizootic lymphangitis, ulcerative 
lymphangitis, strangles and sporotrichosis. The differential diagnosis between these 
diseases should be conducted because of the strict control measures required by legislation, 
and is as follows:
1. Epizootic lymphangitis is a chronic granulomatous and suppurative fungal infection 
chiefly affecting horses (AL-ANI and AL-DELAIMI, 1988). The causative organism is the 
fungus, histoplasma farciminosum. The disease involves the cutaneous lymphatics, may 
be asymptomatic or mild and may result in an apparent recovery persisting as an occult 
infection. Diagnosis can be readily made by the identification of h. farciminosum by 
direct smears and/or culture.
2. Sporotrichosis is a chronic subcutaneous lymphatic mycosis. It occurs only 
sporadically in affected groups of animals and this helps to differentiate it from glanders. 
Positive identification of sporotrichosis could be made on the presence of a gram-positive 
fungus, sporotrichum schenki, which forms single-walled spores.
3. Ulcerative lymphangitis is a bacterial disease of horses and cattle caused by 
Corynebacterium pseudotuberculosis. The disease is characterized by the formation of 
nodules in the subcutaneous tissues, particularly around the fetlock joint. Diagnosis is 
confirmed by isolation of the causative organism (ADDO, 1983).
4. Strangles is an acute bacterial disease of horses caused by streptococcus equi. 
Inflammation of the upper respiratory tract and abscessation of the adjacent lymph nodes 
characterize the disease. The disease responds well to penicillin therapy.
5. Melioidosis (Whitmore’s disease) is caused by Burkholderia pseudomallei. Glanders 
and melioidosis are related diseases. They have similar pathophysiologic consequences, 
although the epidemiology differs. Burkholderia pseudomallei thrive in tropical climates, 
and the disease is endemic in Southeast Asia, the Philippines, Indonesia, and other tropical 
areas. It is most widespread in Thailand, where in one hospital it was responsible for 19% 
of community-acquired sepsis and 40% of deaths from community-acquired septicaemia 
(THUMMAKUL et al., 1999). Both humans and other susceptible animals may contract 
the disease (DANCE, 2000). The organism is distributed widely in soil and water in the 
tropics. It is spread to humans through direct contact with a contaminated source or by 
inhalation of aerosols or dust (THUMMAKUL et al., 1999).
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Treatment and control
As a rule, veterinary authorities forbid the treatment of any equine species which 
proves to be infected with glanders (WOLTER, 1984). All infected animals are killed 
according to laws and legislation. Optimal antibiotic therapy of the disease has not yet 
been determined. Systemic treatment of glanderous horses with antibiotics, including 
penicillin and streptomycin, is usually ineffective in controlling the disease. Although 
there is some contradictory evidence for ampicillin, gentamicin, and tetracycline, 
evidence has accumulated that enrofloxacin (Baytril®), erythromycin, ampicillin, 
sulfonamides, gentamicin and tetracycline might be effective against B. mallei. This 
evidence has emerged from in vitro antibiotic sensitivity testing and from treatment 
studies in experimentally infected guinea pigs (BATMANOV et al., 1996; AL-ANI et al., 
1998). In mice and monkeys doxycycline and ciprofloxacin have been effective therapies 
(RUSSELL et al., 2000; KHOMIAKOV et al., 1998). Recently, excellent results have been 
reported in treating experimentally infected guinea pigs with a single daily 5 mg/kg body 
mass intramuscular dose of enrofloxacin (Baytril®). This regimen may also be beneficial 
in equine glanders (AL-ANI et al., 1998). 
A few antibiotics have been used to treat humans. According to HOWE and MILLER 
(1947) sulfonamides are quite effective in the treatment of man and laboratory animals. 
Sulfadiazine (25 mg/kg intravenously, four times a day) was efficacious in some cases 
(HOWE and MILLER, 1947). For localized infection, a 60- to 150-day course of oral 
amoxicillin and clavulanate may be used. For severe and/or septicemic disease, the initial 
2-week parenteral therapy is followed by oral therapy for 6 months by ceftazidime, 
combined with trimethoprim and sulfamethoxazole. 
FATHI et al. (1953) reported that the combination of a formalized vaccine and 
sulfadiazine is effective in the treatment of horses affected with glanders. Administration 
of one dose of an autogenous vaccine, plus a trimethoprim-sulfonamide combination in a 
daily dose of 20 mg/kg BW for one month, has significantly altered the course of the disease 
in horses with clinical lesions. Horses with advanced lesions usually failed to respond to 
treatment. In areas in which glanders is endemic, routine mallein testing at intervals of 3 
weeks should be conducted until all reactors have been removed (RADOSTITS et al., 1994). 
It is currently recommended that mallein testing and control methods should be instituted 
simultaneously (BLANCOU, 1994a; 1994b). Culling or isolation of all infected horse, 
rearing foals in isolation, and thorough cleaning and disinfecting of the environment may 
help in controlling the disease. All positive cases should be terminated.
Commercial vaccine against glanders is not available. However, the use of a locally 
produced autogenous vaccine may be of importance. In endemic areas, some authors 
recommend routine vaccination of all foals at 6 months of age. Vaccinations are then 
repeated 3 weeks later and then at 6 months intervals thereafter (AL-ANI, 1989). A killed 
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B. mallei vaccine has shown good protective results (MOHLER and EICHORN, 1914; 
ZHANG and LU, 1983).
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SAŽETAK
Sakagija je česta zarazna bolest konja u određenim dijelovima svijeta. Bolest napada i neke druge 
životinjske vrste, a važna je kao zoonoza. Uzročnik je u najnovije doba svrstan u rod Burkholderia. Navode se 
njegove biokemijske značajke. Klinički znakovi bolesti u konja variraju, a očituju se tvorbom čvorova po koži, 
bronhopneumonijom i/ili ulceracijama po nosnoj sluznici. Opisana je dijagnostika, diferencijalna dijagnostika, 
liječenje i kontrola bolesti.
Ključne riječi: sakagija, konj, bakterijska bolest, Burkholderia mallei, zoonoza
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